The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Marson, Anthony; Burnside, Girvan; Appleton, Richard; Smith, Dave; Paul Leach, John; Sills, Graeme; Tudur-Smith, Catrin; Plumpton, Catrin; A Hughes, Dyfrig; Williamson, Paula; A Baker, Gus; Balabanova, Silviya; Taylor, Claire; Brown, Richard; Hindley, Dan; Howell, Stephen; Maguire, Melissa; Mohanraj, Rajiv; E Smith, Philip; Lanyon, Karen; Manford, Mark; Chitre, Manali; Parker, Alasdair; Swiderska, Nina; Appleton, Richard; Pauling, James; Hughes, Adrian; Gupta, Rajat; Hanif, Sadia; Awadh, Mostafa; Ragunathan, Sharmini; Cable, Nicola; Cooper, Paul; Hindley, Daniel; Rakshi, Karl; Molloy, Sophie; Reuber, Markus; Ayonrinde, Kunle; Wilson, Martin; Saladi, Satyanarayana; Gibb, John; Funston, Lesley-Ann; Cassidy, Damhait; Boyd, Jonathan; Ratnayaka, Mal; Faza, Hani; Sadler, Martin; Al-Moasseb, Hassan; Galtrey, Clare; Wren, Damien; Olabi, Anas; Fuller, Geraint; Khan, Muhammed; Kallappa, Chetana; Chinthapalli, Ravi; Aji, Baba; Davies, Rhys; Foster, Kathryn; Hitiris, Nikolas; Maguire, Melissa; Hussain, Nahin; Dowson, Simon; Ellison, Julie; Sharrack, Basil; Gandhi, Vandna; Powell, Rob; Tittensor, Phil; Summers, Beatrice; Shashikiran, Sastry; J Dison, Penelope; Samarasekera, Shanika; McCorry, Doug; White, Kathleen; Nithi, Kannan; Richardson, Martin; Brown, Richard; Page, Rupert; Deekollu, David; Slaght, Sean; Warriner, Stephen; Ahmed, Mansoor; Chaudhuri, Abhijit; Chow, Gabriel; Artal, Javier; Kucinskiene, Danute; Sreenivasa, Harish; Velmurugan,, Singara; S Zipitis, Christos; McLean, Brendan; Lal, Vaithianathar; Gregoriou, Angelous; Maddison, Paul; Pickersgill, Trevor; Anderson, Joseph; Lawthom, Charlotte; Howell, Stephen; Whitlingum, Gabriel; Rakowicz, Wojtek; Kinton, Lucy; McLellan, Alisa; Zuberi, Sameer; Kelso, Andrew; Hughes, Imelda; Martland, John; Emsley, Hedley; de Goede, Christian; Singh, RP; Moor, Carl-Christian; Aram, Julia; Mohanraj, Rajiv; Sakthivel, Kumar; Nelapatla, Suresh; Rittey, Chris; Pinto, Ashwin; Paul Leach, John; Cock, Hannah; Richardson, Anna; Houston, Erika; Cooper, Christopher; Lawson, Geoff; Massarano, Albert; Burness, Christine; Marson, Anthony; Smith, Dave; Wieshmann, Udo; Dey, Indranil; Sivakumar, Puthuval; Yeung, Lap-Kong; Smith, Philip; Bentur, Hemalata; Heafield, Tom; Mathew, Anna; Smith, David; Jauhari, Praveen

doi:10.1016/s0140-6736(21)00246-4

Public

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Shared by NobleBlocks on Apr 1, 2021 • 12:00 AM UTC

Authors:

Anthony Marson

Girvan Burnside

Richard Appleton

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!